Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma
Clinical trial NCT07744529 · RECRUITING
Trial details
- NCT number
- NCT07744529
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-28
- Primary completion
- 2028-05-28
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.